雄烯二酮(CAS 63-05-8):分子式 C19H26O2、分子量 286.4;类别 化工中间体。
雄烯二酮(CAS 63-05-8)是一种化工中间体原料。其分子式 C19H26O2 由 19 个碳、26 个氢、2 个氧 组成。 分子量约为 286.4。公开物性数据显示其熔点约 158、LogP 约 2.75。作为化工品采购代理与分销渠道,我们可在国内及跨境渠道为雄烯二酮寻源比价,并安排小批量试样与批次采购;下单前提供完整 COA、质检报告与合规文件,验收以批次 COA 为准。
登记用途:Anabolic steroids /including 4-androstenedione (DEA Code Number: 4000) are Schedule III controlled substances、Schedule III Controlled Substance: (A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence、MEDICATION、Pharmaceuticals、Methods of Manufacturing: Androstanes、pregnanes without the C-17 side chain。
雄烯二酮 是一种化工中间体化合物,登记 CAS 号为 63-05-8,分子式 C19H26O2(分子量 286.4),归属于化工中间体大类化工原料。
登记 CAS 号:63-05-8
其分子式 C19H26O2 由 19 个碳、26 个氢、2 个氧 组成。
别名/同义词:雄烯二酮 · Androstenedione
所属分类:化工中间体
雄烯二酮 的 CAS 登记号为 63-05-8。
分子式 C19H26O2,分子量 286.4。
别名/同义词:雄烯二酮、Androstenedione。
登记用途:Anabolic steroids /including 4-androstenedione (DEA Code Number: 4000) are Schedule III controlled substances、Schedule III Controlled Substance: (A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. (B) The drug or other substance has a currently accepted medical use in treatment in the United States. (C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence、MEDICATION、Pharmaceuticals、Methods of Manufacturing: Androstanes、pregnanes without the C-17 side chain。
所属分类:化工中间体。
请在联系页面提交产品名称、CAS 号与数量,我们作为采购代理在国内及跨境渠道为您寻源比价,安排试样与批次采购,下单前提供 COA 与合规文件。
包装按订单确认,从实验室小包装到吨袋大货,随订单安排而非在页面上写死。每批随货附 COA 分析证书,可另提供 MSDS;若终端用途带有法规限度(食品接触、药品或化妆品),请在询价时说明执行标准,等级按该标准确定。
雄烯二酮(CAS 63-05-8)的公开数据库记录,列此仅供独立核对。
| Reported hazard statements | H302 (97.9%), H351 (95.8%), H360 (93.8%), H362 (95.8%) |
|---|
H302 (97.9%): Harmful if swallowed [Warning Acute toxicity, oral]
H351 (95.8%): Suspected of causing cancer [Warning Carcinogenicity]
| 熔点 | 158 |
|---|---|
| 熔点 | 170 - 173 °C |
| 溶解度 | 57.8 |
| 溶解度 | 0.0578 mg/mL |
| LogP | 2.75 |
| LogP | log Kow = 2.75 |
| Collision Cross Section | 182.8 Ų [M+H]+ |
| Collision Cross Section | 203.4 Ų [M+Na]+ |
| Collision Cross Section | 172.5 Ų [M+H]+ |
| CAS Registry Number | 63-05-8 |
|---|---|
| PubChem CID | 6128 |
| 分子式 | C19H26O2 |
| IUPAC 名称 | (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione |
| UNII(FDA) | 409J2J96VR |
androstenedione; Androst-4-ene-3,17-dione; 4-Androstene-3,17-dione; 63-05-8; 4-Androstenedione; Androtex; delta-4-Androstenedione; 3,17-Dioxoandrost-4-ene; SKF 2170; delta-4-Androsten-3,17-dione; DTXSID8024523; NSC 9563; delta(sup 4)-Androstene-3,17-dione; NSC-9563; (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione; CHEBI:16422
| 分子量 | 286.4 |
|---|---|
| XLogP3 | 2.7 |
| 氢键供体数 | 0 |
| 氢键受体数 | 2 |
| 可旋转键数 | 0 |
| 精确质量 | 286.193280068 |
| 单同位素质量 | 286.193280068 |
| 拓扑极性表面积 | 34.1 |
| 重原子数 | 21 |
| 形式电荷 | 0 |
Androstenedione · CAS 63-05-8 · C19H26O2. UNII 409J2J96VR. 熔点: 158; 熔点: 170 - 173 °C; 溶解度: 57.8.
数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。
English page: Androstenedione